NovaSterilis is the global leader in the applications of supercritical carbon dioxide (scCO2) on biomaterials including the decellularization and sterilization of allograft and xenograft tissues. NovaSterilis'​ processes have been used to treat ortho/dental/spinal products used in over 300,000 surgeries over the past 8 years. scCO2 involves lower temperatures (31°C) and pressure above 1100 psi. This lower temperature makes scCO2 ideal for materials which are temperature sensitive or reactive with other forms of sterilization. scCO2 can penetrate and sterilize delicate products and materials, such as allograft tissue, without damage to the products structural or chemical integrity. The Nova2200™ commercial sterilizer utilizes NovaSterilis'​ patented technology to provide a state-of-the-art, gentle sterilization for different types of musculo-skeletal tissues such as bone, tendon, skin and other types of tissue. The Nova2200™ process achieves Sterility Assurance Level of 10-6 (SAL6) while maintaining the bio-mechanical properties and quality of the allograft.

Supercritical Carbon Dioxide Sterilization Decellularization Terminal Sterilization Supercritical Carbon Dioxide Allografts Xenografts Donor Tissue ECM Pericardium R&D Equipment CRO Biomaterials Pressure Vessel Process Validation Microbiology Testing Material Compatability Cannabis Sterilization Endoscope Sterilization Tissue Banking Supercritical Fluids Carbon Dioxide R&D Equipment Medical Equipment Medical and Hospital Equipment Medical Devices